The burden of all-cause mortality following influenza-associated hospitalizations, FluSurv-NET, 2010-2019.

Autor: O'Halloran AC; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA., Millman AJ; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA., Holstein R; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA., Olsen SJ; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA., Cummings C; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA., Chai SJ; California Emerging Infections Program, Oakland, CA, USA.; Centers for Disease Control and Prevention, Office of Readiness and Response, Atlanta, GA, USA., Kirley PD; California Emerging Infections Program, Oakland, CA, USA., Alden NB; Colorado Department of Public Health & Environment, Denver, CO, USA., Yousey-Hindes K; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, USA., Meek J; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, USA., Openo KP; Emory University School of Medicine, Atlanta, GA, USA.; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, GA, USA.; Atlanta Veterans Affairs Medical Center, Decatur, GA, USA., Fawcett E; Emory University School of Medicine, Atlanta, GA, USA.; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, GA, USA.; Atlanta Veterans Affairs Medical Center, Decatur, GA, USA., Ryan PA; Maryland Department of Health, Baltimore, MD, USA., Leegwater L; Michigan Department of Health and Human Services, Lansing, MI, USA., Henderson J; Michigan Department of Health and Human Services, Lansing, MI, USA., McMahon M; Minnesota Department of Health, St. Paul, MN, USA., Lynfield R; Minnesota Department of Health, St. Paul, MN, USA., Angeles KM; New Mexico Emerging Infections Program, Albuquerque, NM, USA., Bleecker M; New Mexico Emerging Infections Program, Albuquerque, NM, USA., McGuire S; New York State Department of Health, Albany, NY, USA., Spina NL; New York State Department of Health, Albany, NY, USA., Tesini BL; University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., Gaitan MA; University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., Lung K; Ohio Department of Health, Columbus, OH, USA., Shiltz E; Ohio Department of Health, Columbus, OH, USA., Thomas A; Public Health Division, Oregon Health Authority, Portland, OR, USA., Talbott HK; Vanderbilt University Medical Center, Nashville, TN, USA., Schaffner W; Vanderbilt University Medical Center, Nashville, TN, USA., Hill M; Salt Lake County Health Department, Salt Lake City, UT, USA., Reed C; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA., Garg S; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Nov 04. Date of Electronic Publication: 2024 Nov 04.

Laboratory-Confirmed Influenza-Associated Hospitalizations Among Children and Adults - Influenza Hospitalization Surveillance Network, United States, 2010-2023.

Autor: Naquin A, O'Halloran A, Ujamaa D, Sundaresan D, Masalovich S, Cummings CN, Noah K, Jain S, Kirley PD, Alden NB, Austin E, Meek J, Yousey-Hindes K, Openo K, Witt L, Monroe ML, Henderson J, Nunez VT, Lynfield R, McMahon M, Shaw YP, McCahon C, Spina N, Engesser K, Tesini BL, Gaitan MA, Shiltz E, Lung K, Sutton M, Hendrick MA, Schaffner W, Talbot HK, George A, Zahid H, Reed C, Garg S, Bozio CH

Publikováno v: Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) [MMWR Surveill Summ] 2024 Oct 31; Vol. 73 (6), pp. 1-18. Date of Electronic Publication: 2024 Oct 31.

Timing of influenza antiviral therapy and risk of death in adults hospitalized with influenza-associated pneumonia, FluSurv-NET, 2012-2019.

Autor: Tenforde MW; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Noah KP; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., O'Halloran AC; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Kirley PD; California Emerging Infections Program, Oakland, CA, USA., Hoover C; California Department of Public Health, Richmond, California, USA., Alden NB; Colorado Department of Public Health and Environment, Denver, Colorado, USA., Armistead I; Colorado Department of Public Health and Environment, Denver, Colorado, USA., Meek J; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA., Yousey-Hindes K; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA., Openo KP; Georgia Emerging Infections Program, Atlanta, Georgia, USA.; Emory University School of Medicine, Atlanta, Georgia, USA.; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia, USA., Witt LS; Georgia Emerging Infections Program, Atlanta, Georgia, USA.; Emory University School of Medicine, Atlanta, Georgia, USA., Monroe ML; Maryland Department of Health, Baltimore, Maryland, USA., Ryan PA; Maryland Department of Health, Baltimore, Maryland, USA., Falkowski A; Michigan Department of Health and Human Services, Lansing, Michigan, USA., Reeg L; Michigan Department of Health and Human Services, Lansing, Michigan, USA., Lynfield R; Minnesota Department of Health, St. Paul, Minnesota, USA., McMahon M; Minnesota Department of Health, St. Paul, Minnesota, USA., Hancock EB; New Mexico Emerging Infections Program, Santa Fe, New Mexico, USA., Hoffman MR; New Mexico Emerging Infections Program, Santa Fe, New Mexico, USA., McGuire S; New York State Department of Health, Albany, New York, USA., Spina NL; New York State Department of Health, Albany, New York, USA., Felsen CB; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA., Gaitan MA; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA., Lung K; Ohio Department of Health, Columbus, Ohio, USA., Shiltz E; Ohio Department of Health, Columbus, Ohio, USA., Thomas A; Oregon Health Authority, Salem, OR, USA., Schaffner W; Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Talbot HK; Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Crossland MT; Salt Lake County Health Department, Salt Lake City, Utah, USA., Price A; Salt Lake County Health Department, Salt Lake City, Utah, USA., Masalovich S; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Adams K; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Holstein R; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Sundaresan D; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Uyeki TM; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Reed C; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Bozio CH; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Garg S; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 22. Date of Electronic Publication: 2024 Aug 22.

Characteristics and Outcomes of Pregnant Women Hospitalized With Laboratory-Confirmed Respiratory Syncytial Virus Before and During the COVID-19 Pandemic.

Autor: Milucky J; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Patel K; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Patton ME; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Kirley PD; California Emerging Infections Program, Oakland, California, USA., Austin E; Colorado Department of Public Health and Environment, Denver, Colorado, USA., Meek J; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA., Anderson EJ; Departments of Medicine and Pediatrics, School of Medicine, Emory University, Atlanta, Georgia, USA.; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, Georgia, USA.; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia, USA., Brooks A; Maryland Department of Health, Baltimore, Maryland, USA., Brown C; Michigan Department of Health and Human Services, Lansing, Michigan, USA., Mumm E; Minnesota Department of Health, St Paul, Minnesota, USA., Salazar-Sanchez Y; New Mexico Department of Health, Santa Fe, New Mexico, USA., Barney G; New York State Department of Health, Albany, New York, USA., Popham K; School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA., Sutton M; Public Health Division, Oregon Health Authority, Portland, Oregon, USA., Talbot HK; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Crossland MT; Salt Lake County Health Department, Salt Lake City, Utah, USA., Havers FP; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 31; Vol. 11 (3), pp. ofae042. Date of Electronic Publication: 2024 Jan 31 (Print Publication: 2024).

Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010-19: a repeated cross-sectional study.

Autor: Sumner KM; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA; Epidemic Intelligence Service, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: rhq3@cdc.gov., Masalovich S; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA., O'Halloran A; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Holstein R; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Reingold A; School of Public Health, University of California Berkeley, Berkeley, CA, USA., Kirley PD; California Emerging Infections Program, Oakland, CA, USA., Alden NB; Colorado Department of Public Health and Environment, Denver, CA, USA., Herlihy RK; Colorado Department of Public Health and Environment, Denver, CA, USA., Meek J; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, USA., Yousey-Hindes K; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, USA., Anderson EJ; Department of Medicine and Depatment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, GA, USA; Veterans Affairs Medical Center, Atlanta, GA, USA., Openo KP; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, GA, USA; Veterans Affairs Medical Center, Atlanta, GA, USA., Monroe ML; Maryland Department of Health, Baltimore, MD, USA., Leegwater L; Michigan Department of Health and Human Services, Lansing, MI, USA., Henderson J; Michigan Department of Health and Human Services, Lansing, MI, USA., Lynfield R; Minnesota Department of Health, Saint Paul, MN, USA., McMahon M; Minnesota Department of Health, Saint Paul, MN, USA., McMullen C; New Mexico Department of Health, Santa Fe, NM, USA., Angeles KM; New Mexico Emerging Infections Program, University of New Mexico, Albuquerque, NM, USA., Spina NL; New York State Department of Health, Albany, NY, USA., Engesser K; New York State Department of Health, Albany, NY, USA., Bennett NM; University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., Felsen CB; University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., Lung K; Ohio Department of Health, Columbus, OH, USA., Shiltz E; Ohio Department of Health, Columbus, OH, USA., Thomas A; Oregon Health Authority, Salem, OR, USA., Talbot HK; Vanderbilt University Medical Center, Nashville, TN, USA., Schaffner W; Vanderbilt University Medical Center, Nashville, TN, USA., Swain A; Salt Lake County Health Department, Salt Lake City, UT, USA., George A; Salt Lake County Health Department, Salt Lake City, UT, USA., Rolfes MA; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Reed C; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Garg S; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA.

Publikováno v: The Lancet. Microbe [Lancet Microbe] 2023 Nov; Vol. 4 (11), pp. e903-e912. Date of Electronic Publication: 2023 Sep 25.